SKP2 and gastric cancer: The results of our study showed that the oncogenic ability of cell proliferation and cancer promotion, represented by SKP2 expression in gastric cancer tissues, was repressed by the expression of Beclin-1 and FOXP3 and thus responded to the survival outcome.